Angiopoietins-1 and -2 play opposing roles in endothelial sprouting of embryoid bodies in 3D culture and their receptor Tie-2 associates with the cell-cell adhesion molecule PECAM1.

Angiopoietins 1 and 2, ligands for the receptor kinase Tie-2, have been proposed to play critical but opposing roles in vascular development. Since signaling by Tie-2 is likely affected by other endothelial cell receptors such as Flk-1, the receptor for VEGF, and cell-cell adhesion receptors PECAM1 and VE-cad, we explored their interactions in a 3D model of vasculogenesis. When murine embryoid bodies (EBs) were treated with VEGF in Matrigel in the presence or absence of Ang-1 or Ang-2 for eight days, Ang-1 abrogated vascular sprouting for treatments started at days 0 or 3. In contrast, Ang-2 greatly accelerated vascular sprouting compared to untreated EBs. These results were confirmed in a second model system where VEGF treated HUVECs were grown in Matrigel in the presence or absence of Ang-1 or Ang-2. Since vascular sprouting must be precisely controlled in the developing embryo, it is likely that cell-cell adhesion molecules play a role in sensing the density of vascular sprouts. In this respect, we have shown that PECAM1 and CEACAM1 play essential roles in vascular sprouting. We now show that PECAM1 is associated with Tie-2, becomes phosphorylated on its ITIMs, and recruits the inhibitory phosphatases SHP-1 and SHP-2. In addition, PECAM1 is associated with VE-cad and may similarly regulate its signaling via recruitment of SHP-1/2.

[1]  S. Gory-Fauré,et al.  Role of vascular endothelial-cadherin in vascular morphogenesis. , 1999, Development.

[2]  S. Oikawa,et al.  Homotypic and heterotypic Ca(++)-independent cell adhesion activities of biliary glycoprotein, a member of carcinoembryonic antigen family, expressed on CHO cell surface. , 1992, Biochemical and biophysical research communications.

[3]  Mohammad Tabrizi,et al.  A Human Monoclonal Anti-ANG2 Antibody Leads to Broad Antitumor Activity in Combination with VEGF Inhibitors and Chemotherapy Agents in Preclinical Models , 2010, Molecular Cancer Therapeutics.

[4]  E. Dejana,et al.  Interendothelial Junctions and their Role in the Control of Angiogenesis, Vascular Permeability and Leukocyte Transmigration , 2001, Thrombosis and Haemostasis.

[5]  S. Gray-Owen,et al.  Neisserial binding to CEACAM1 arrests the activation and proliferation of CD4+ T lymphocytes , 2002, Nature Immunology.

[6]  J. Shively,et al.  Role of Ceacam1 in VEGF induced vasculogenesis of murine embryonic stem cell-derived embryoid bodies in 3D culture. , 2009, Experimental cell research.

[7]  W. Shim,et al.  Angiopoietin: A TIE(d) Balance in Tumor Angiogenesis , 2007, Molecular Cancer Research.

[8]  Pamela F. Jones,et al.  Isolation of Angiopoietin-1, a Ligand for the TIE2 Receptor, by Secretion-Trap Expression Cloning , 1996, Cell.

[9]  E. Dejana,et al.  The role of JAM‐A and PECAM‐1 in modulating leukocyte infiltration in inflamed and ischemic tissues , 2006, Journal of leukocyte biology.

[10]  D. Rimm,et al.  PECAM-1 (CD31) functions as a reservoir for and a modulator of tyrosine-phosphorylated beta-catenin. , 1999, Journal of cell science.

[11]  P. Kingsley,et al.  Initiation of hematopoiesis and vasculogenesis in murine yolk sac explants. , 1995, Blood.

[12]  W. Muller Leukocyte-endothelial-cell interactions in leukocyte transmigration and the inflammatory response. , 2003, Trends in immunology.

[13]  M. Corada,et al.  Contact inhibition of VEGF-induced proliferation requires vascular endothelial cadherin, β-catenin, and the phosphatase DEP-1/CD148 , 2003, The Journal of cell biology.

[14]  M. Mareel,et al.  Clinical, cellular, and molecular aspects of cancer invasion. , 2003, Physiological reviews.

[15]  F. Orsenigo,et al.  Vascular endothelial cadherin controls VEGFR-2 internalization and signaling from intracellular compartments , 2006, The Journal of cell biology.

[16]  J. Shively,et al.  The Cell-Cell Adhesion Molecule Carcinoembryonic Antigen-Related Cellular Adhesion Molecule 1 Inhibits IL-2 Production and Proliferation in Human T Cells by Association with Src Homology Protein-1 and Down-Regulates IL-2 Receptor1 , 2004, The Journal of Immunology.

[17]  H. Huland,et al.  Dual Role of Carcinoembryonic Antigen-Related Cell Adhesion Molecule 1 in Angiogenesis and Invasion of Human Urinary Bladder Cancer , 2004, Cancer Research.

[18]  Y. Kanai,et al.  Localization of Ang-1, -2, Tie-2, and VEGF expression at endothelial-pericyte interdigitation in rat angiogenesis , 2006, Laboratory Investigation.

[19]  Yun Li,et al.  Direct Interaction of Tumor Suppressor CEACAM1 with Beta Catenin: Identification of Key Residues in the Long Cytoplasmic Domain , 2008, Experimental biology and medicine.

[20]  N. Kilic,et al.  Pro-angiogenic Signaling by the Endothelial Presence of CEACAM1* , 2005, Journal of Biological Chemistry.

[21]  S. Ergün,et al.  CEA-related cell adhesion molecule 1: a potent angiogenic factor and a major effector of vascular endothelial growth factor. , 2000, Molecular cell.

[22]  S. Albelda,et al.  Molecular and cellular properties of PECAM-1 (endoCAM/CD31): a novel vascular cell-cell adhesion molecule , 1991, The Journal of cell biology.

[23]  P. Carmeliet,et al.  Targeted Deficiency or Cytosolic Truncation of the VE-cadherin Gene in Mice Impairs VEGF-Mediated Endothelial Survival and Angiogenesis , 1999, Cell.

[24]  S. von Kleist,et al.  Biliary glycoprotein (CD66a), a cell adhesion molecule of the immunoglobulin superfamily, on human lymphocytes: structure, expression and involvement in T cell activation , 1998, European journal of immunology.

[25]  B. Imhof,et al.  Platelet-endothelial cell adhesion molecule-1 (PECAM-1/CD31) tyrosine phosphorylation state changes during vasculogenesis in the murine conceptus. , 1997, The American journal of pathology.

[26]  S. Nourshargh,et al.  PECAM-1: a multi-functional molecule in inflammation and vascular biology. , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[27]  T. Mak,et al.  Genetic evidence for functional redundancy of Platelet/Endothelial cell adhesion molecule-1 (PECAM-1): CD31-deficient mice reveal PECAM-1-dependent and PECAM-1-independent functions. , 1999, Journal of immunology.

[28]  Thomas N. Sato,et al.  Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. , 1997, Science.

[29]  M. Corada,et al.  VE‐cadherin is a critical endothelial regulator of TGF‐β signalling , 2008, The EMBO journal.

[30]  S. Ergün,et al.  Angiogenic properties of the carcinoembryonic antigen-related cell adhesion molecule 1. , 2000, Experimental cell research.

[31]  M. Meissner,et al.  Down-regulation of vascular endothelial growth factor receptor 2 is a major molecular determinant of proteasome inhibitor-mediated antiangiogenic action in endothelial cells. , 2009, Cancer research.

[32]  N. Beauchemin,et al.  The Carboxyl-terminal Region of Biliary Glycoprotein Controls Its Tyrosine Phosphorylation and Association with Protein-tyrosine Phosphatases SHP-1 and SHP-2 in Epithelial Cells* , 1999, The Journal of Biological Chemistry.

[33]  Janet Rossant,et al.  Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice , 1995, Nature.

[34]  J. Rossant,et al.  tek, a novel tyrosine kinase gene located on mouse chromosome 4, is expressed in endothelial cells and their presumptive precursors. , 1992, Oncogene.

[35]  M. Gertsenstein,et al.  Dominant-negative and targeted null mutations in the endothelial receptor tyrosine kinase, tek, reveal a critical role in vasculogenesis of the embryo. , 1994, Genes & development.

[36]  C. Mickanin,et al.  Platelet endothelial cell adhesion molecule-1 (PECAM-1/CD31): alternatively spliced, functionally distinct isoforms expressed during mammalian cardiovascular development. , 1994, Development.

[37]  J. Lilien,et al.  The regulation of cadherin-mediated adhesion by tyrosine phosphorylation/dephosphorylation of beta-catenin. , 2005, Current opinion in cell biology.

[38]  M. Achtman,et al.  Carcinoembryonic Antigen Family Receptor Specificity of Neisseria meningitidis Opa Variants Influences Adherence to and Invasion of Proinflammatory Cytokine-Activated Endothelial Cells , 2000, Infection and Immunity.

[39]  D. Nikolov,et al.  Tie1-Tie2 interactions mediate functional differences between angiopoietin ligands. , 2010, Molecular cell.

[40]  J. Lilien,et al.  Turn‐off, drop‐out: Functional state switching of cadherins , 2002, Developmental dynamics : an official publication of the American Association of Anatomists.

[41]  R. Raychowdhury,et al.  Activation-Induced Expression of Carcinoembryonic Antigen-Cell Adhesion Molecule 1 Regulates Mouse T Lymphocyte Function1 , 2002, The Journal of Immunology.

[42]  Urban Deutsch,et al.  Angiopoietin-1 induces sprouting angiogenesis in vitro , 1998, Current Biology.

[43]  G. Garcı́a-Cardeña,et al.  Direct actions of angiopoietin-1 on human endothelium: evidence for network stabilization, cell survival, and interaction with other angiogenic growth factors. , 1999, Laboratory investigation; a journal of technical methods and pathology.

[44]  U. Schumacher,et al.  Carcinoembryonic antigen-related cell adhesion molecule 1 modulates vascular remodeling in vitro and in vivo. , 2006, The Journal of clinical investigation.

[45]  Cunji Gao,et al.  The cell-adhesion and signaling molecule PECAM-1 is a molecular mediator of resistance to genotoxic chemotherapy , 2006, Cancer biology & therapy.